Secured Research | Equipment Finance Originator | Monitor | Monitor Suite | Converge | STRIPES Leadership
No Result
View All Result
ABF Journal
Forward for Specialty Finance
SUBSCRIBE
Lender & Services Directory
  • News
    • People
    • Economy
    • All News
  • Deals
  • Magazine
    • Magazine Issues
    • Nominations
  • Features
  • Recruiting
  • Events
  • Advertise
  • Contact Us
  • News
    • People
    • Economy
    • All News
  • Deals
  • Magazine
    • Magazine Issues
    • Nominations
  • Features
  • Recruiting
  • Events
  • Advertise
  • Contact Us
No Result
View All Result
ABF Journal
No Result
View All Result
Home Deal Announcements

K2 HealthVentures Provides $50MM in Financing to Invaio Sciences

byIan Koplin
October 14, 2021
in Deal Announcements

Invaio Sciences, a Flagship Pioneering company using natural systems to accelerate the transition to sustainable agriculture to address climate change, entered into a $50 million loan and security agreement with K2 HealthVentures, a healthcare and life sciences-focused investment firm.

Invaio Sciences will use the funds to accelerate the research, development and commercialization of its platforms, which are focused on discovering natural active ingredients, developing unique precision delivery systems and understanding novel modes of action. Invaio’s solutions have the potential to reduce the use of chemical pesticides and fertilizers, conserve more water and improve the efficiency of the agricultural food system for the benefit of consumers and the planet.

“Invaio’s partnership with K2HV will help us expand our geographic footprint and accelerate the development of breakthrough platforms focused on developing integrated solutions in three market segments: perennials, row crops and vegetable crops,” Ignacio Martinez, co-founder and CEO of Invaio Sciences and general partner at Flagship Pioneering, said. “Our ambition is to build the most impactful and valuable crop health company on the planet. The world is changing quickly and food production practices must adapt to keep pace with evolving consumer demands, changing environmental conditions and increased stress on ecological resources.”

“Thankfully, over the last two decades, human disease management has increasingly utilized safer and more effective precision medicine techniques. The agricultural world has not shifted to this paradigm and still suffers from ineffective pest and disease management and harmful consequences to the environment. We believe Invaio’s suite of platform technologies is the precision medicine answer for the agriculture world,” Parag Shah, founding managing director and CEO of K2 HealthVentures, said. “This financing follows our strategy of partnering with pioneering life science technology companies with world class management that aim to deliver solutions for critical global challenges.”

Previous Post

Cerebro Capital Hires Dalo as EVP and Hsu as VP of Marketing

Next Post

Sterling National Bank Adds Stansbery as Managing Director of Franchise Originations

Related Posts

Advanced Power Closes $100M Corporate Credit Facility
Deal Announcements

Horizon Technology Finance Provides $25MM Loan Facility to Stellar Cyber

April 17, 2026
Deal Announcements

eCapital Provides $15MM ABL Facility to California-Based Metal Wholesaler

April 17, 2026
Deal Announcements

TRUNO Completes Recapitalization and Closes New $40MM Credit Facility

April 17, 2026
Deal Announcements

Southstar Capital Delivers $1.5MM Invoice Factoring Facility to Support Logistics Company

April 17, 2026
Advanced Power Closes $100M Corporate Credit Facility
Deal Announcements

White Oak Provides $65MM ABL Revolving Credit Facility to Support Recapitalization of Manufacturer

April 16, 2026
Advanced Power Closes $100M Corporate Credit Facility
Deal Announcements

BofA Leads $450MM U.S. Physical Therapy Credit Facility

April 16, 2026
Next Post

Sterling National Bank Adds Stansbery as Managing Director of Franchise Originations

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Irreconcilable Differences:  How MCA Abuse of “Reconciliation Rights” Threatens Collateral

A Workout Without the Mess: When is Article 9 Restructuring the Right Path?

March 19, 2026

The Clean Slate: Mastering Article 9 Restructuring

March 27, 2026

The PIK Divide: Separating Structural Flexibility from Shadow Distress in Private Credit

April 3, 2026

The Rise of Insurance-Linked Capital in Private Credit

April 13, 2026

About Us

For over 50 years, RAM Holdings’ brands have led the commercial finance industry in publishing, talent development, research and events. ABF Journal’s audience is comprised of as many as 18,000 specialty finance industry executives, private equity investors, investment bankers, advisors, service providers and more.

Our Brands

  • Secured Research
  • Equipment Finance Originator
  • Monitor
  • Monitor Suite
  • Converge
  • STRIPES Leadership

 

Learn More

  • Advertise
  • Magazine
  • Contact Us

Newsletter

Driving specialty finance forward for decades with insights, recognition and deals. Sign up now.

SUBSCRIBE >>

© 2025 RAM Group Holdings - A Leading Commercial Finance Publishing Group For Over 50 Years

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • News
    • People
    • Economy
    • All News
  • Deals
  • Features
  • Magazine
    • Magazine Issues
    • Nominations
  • Events
  • Advertise
  • Contact Us
Provider Directory >>

© 2025 RAM Group Holdings - A Leading Commercial Finance Publishing Group For Over 50 Years